MONACO, July 14, 2026 /PRNewswire/ -- The Rigmora Biotech Investors welcome the order issued July 10th 2026 by Hon. Justice Jalil Asif KC of the Grand Court of the Cayman Islands.
Following the hearing on July 1, the court determined that control of ATP Life Sciences Ventures L.P. ("the Fund") should be taken away from the current General Partner, ATP III GP Ltd, which is led by Dr. Seth Harrison. With immediate effect the Fund will be managed by independent office holders appointed by the Grand Court, Mr. Alexander Lawson and Mr. Barry Lynch of Alvarez & Marsal.
The Rigmora Biotech Investors are convinced that the immediate removal of the current General Partner's control over the Fund, with the future management of the Fund to be conducted by professional and independent office holders, is in the best interest of the Fund and will result in maximization of the Fund's value.
Brian Cattell, CLP Strategies [email protected]
Source: Rigmora Biotech Investors
{fullname}
About author
You should write because you love the shape of stories and sentences and the creation of different words on a page.
View all posts
Related posts
---
Purchasers of Quantstamp QSP Tokens May Be Eligible for Payment from the Quantstamp Fair Fund
COSTA MESA, Calif., Jan. 22, 2025 /PRNewswire/ -- The following statement is being issued by Simpluris,
---
E Fund HK's Chief Investment Officer, Global Equity - Jeff Li Highlights "Three Foundational Shifts" at Bloomberg Invest Hong Kong 2026
HONG KONG, June 11, 2026 /PRNewswire/ -- Following yesterday's Bloomberg Invest Hong Kong 2026 conference,
---
ALL INDIVIDUALS WHO PURCHASED OR ACQUIRED IMPACT THEORY FOUNDER'S KEYS BETWEEN OCTOBER 13, 2021, AND DECEMBER 6, 2021
COSTA MESA, Calif., Feb. 24, 2025 /PRNewswire/ -- The following statement is being issued by Simpluris, Inc.,
---
Innoscience Secures Removal of Court-Enjoined Infineon GaN Products from Display at electronica China 2026
SHANGHAI, July 2, 2026 /PRNewswire/ -- Infineon Technologies was forced to remove certain gallium nitride
